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Mycotic aortic aneurysms are rare and it is unlikely that any center will obtain extensive experience in their management.
The aim of treatment is to repair the aorta and eradicate the infection with minimal operative and postoperative risk. We
describe a case in which a custom-made endovascular stent graft provided the optimal treatment strategy and remained
durable at 4 years of follow-up. (J Vasc Surg 2010;51:1272-5.)Mycotic aortic aneurysms are rare, accounting for
0.65% to 1.3% of all aortic aneurysms.1,2 Peak prevalence is
in the seventh decade of life and formation associated with
atherosclerotic plaque and immunosuppression.3 Morpho-
logically, they are saccular. Rapid growth is common and
classic presentation is with aortic rupture. Organisms are
isolated from blood culture in approximately 50% to 75% of
cases and are predominantly Staphylococcus, Streptococcus,
and Salmonella species.4,5
Worldwide, the prevalence of mycobacterium tubercu-
lous (TB) is increasing, but associated aneurysm of the aorta
is rare.6 At Boston City Hospital, over a 50-year period,
22,792 necropsies were performed, 338 aortic aneurysms
were identified, and only one was tuberculous in origin.7
Despite advances in antibiotic therapy, pure medical
treatment often results in persistent aortic infection, rup-
ture, and death.8 Operative intervention is associated with
mortality in the region of 21% to 36% andmorbidity such as
aortic stump rupture and amputation in up to 50%. Aneu-
rysms within the thorax are associated with considerably
higher rates of cardiovascular and pulmonary complica-
tions.9
Endovascular stent grafts are now well-established
for treatment of degenerative aneurysms, and their use in
infected fields is emerging.10 Commercially available,
custom-made devices provide patient-specific treatment
and have an important role in the management of complex
aortic anatomy.11 Long manufacturing time has previously
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1272prevented the use of these devices for treatment of mycotic
aneurysms. We present a case of successful treatment of a
tuberculous mycotic aneurysm using a custom-made endo-
vascular device combined with medical therapy. The repair
has proved durable and the patient remains well at 4-year
follow-up.
CASE REPORT
A 49-year-old South African nurse, resident in the United
Kingdom for 12 months, presented to the emergency department
with breathlessness, weight loss, and fever. A chest radiograph
revealed fine nodular shadowing throughout both lung fields
consistent with miliary TB. Bronchial lavage and brushings were
sterile. No aortic pathology was seen on computed tomography
(CT). Drainage of a concurrent paraspinal collection demonstrated
acid-fast bacilli with Ziehl-Neelsen stain. The patient was started
on a 6-month medication course of ethambutol, rifampicin, pyri-
doxine, and isoniazid. Serologic results for human immunodefi-
ciency virus were negative.
The patient was not compliant with treatment and returned 5
months later with back pain and was apyrexial with a leukocyte
count of 4.0  109 and an erythrocyte sedimentation rate of 22
mm/hour. Angiography illustrated a supraceliac (10 mm from
celiac artery origin), infradiaphragmatic saccular, false aortic aneu-
rysmwhichmeasured 6.8 cm onCTwith intravenous contrast (Fig
1). There was no extravasation of contrast. The patient was stable
and, therefore, a custom-made device was ordered and delivered
after 8 weeks. Endovascular repair was performed under epidural
anesthesia with a right femoral arteriotomy to accommodate the
custom-made Cook device (Cook 22/50; Cook Medical Inc,
Bloomington, Ind), which was contained in a 22F sheath. A 5F
catheter was inserted in the contralateral groin so that continuous
angiography could be performed during device deployment. The
device with distal bare fixation was deployed over a stiff guidewire
under fluoroscopic guidance. The covered part was positioned
immediately above the celiac axis, and the distal bare stent covered
the celiac artery, providing a secure fixation. Postprocedure imag-
ing demonstrated satisfactory stent graft position, complete exclu-
sion of the aneurysm, no endoleak, and antegrade flow in the celiac
axis (Fig 2). The postoperative course was uncomplicated and,
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home 3 days later on oral anti-TB medication. In view of the fact
that there was no clinical, hematologic, or radiologic evidence of
infection, a multidisciplinary team comprised of surgeons, inter-
ventional radiologists, and microbiologists made the decision to
stop the antibiotics at 3 months. Four years after the procedure,
the patient remains well on both clinical and imaging follow-up
Fig 1. Preoperative angiography (left) and computed
strating location of the aneurysm.
Fig 2. Postoperative angiography illustrating successful exclusion
of the aneurysm and antegrade flow in the celiac artery.(Fig 3).DISCUSSION
This case illustrates the successful management of a
patient with a tuberculous mycotic aortic aneurysm using
combined medical therapy and a commercially available
custom-made endovascular stent graft.
The use of stent grafts for the treatment of mycotic
aneurysms is emerging and still associated with some skep-
ticism. The results of the larger clinical series have shown
improved early mortality and morbidity compared to open
operative repair.12,13 Careful patient selection is an impor-
tant determinant of success, and patients who are relatively
sterile at the time of stent graft deployment have been
shown to have less long-term infective complications. Ad-
junctive procedures, such as drainage of paraspinal collec-
tions, are relatively protective from persistent infection, and
antibiotic-soaked grafts may have a role.14
Reports of endovascular repair of TB mycotic aortic
graphy (CT) with intravenous contrast (right) demon-
Fig 3. Computed tomography (CT) with intravenous contrast at
4 years showing resolution of the aneurysm.tomoaneurysms have hadmixed success (Table).15-17 Two of the
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May 20101274 Clough et al4 patients had a poor outcome. One patient with an aorto-
pulmonary-cutaneous fistula died of rupture at 20 months;
the endograft was probably reinfected by a large pulmonary
cavern which rendered antibiotics ineffective.16 Another
patient had an intraoperative posterior circulation infarct.17
In the current patient, the risk of paraplegia was low, as the
device measured only 5.5 cm, and the risk of stroke was low
because the aneurysm was located in the distal thoracic
aorta. In common with aneurysms of other microbiological
etiology, the presence of an aortic fistula is a poor prognos-
tic indicator and simple aneurysms with adjunctive proce-
dures, such as drainage of collections, tend to do better.
The patient presented in this report was relatively sterile at
the time of stent graft deployment, had a simple aneurysm,
and the paraspinal abscess had been drained. A relatively
short course of postoperative antibiotics was, therefore,
appropriate in this case.
Immunocompromise due to either concurrent illness,
such as carcinoma or diabetes or due tomedication, has also
been proposed as a risk factor for development of mycotic
aneurysms and for problems with long-term infective com-
plications.
The optimal treatment of mycotic aortic aneurysms
remains complex. These aneurysms are rare and so it is
unlikely that a single center will gain a great experience,
therefore, each patient should be treated on an individual
basis. Close cooperation with interventional and microbio-
logic teams is imperative.
CONCLUSION
Endovascular repair of a tuberculous mycotic aortic
aneurysm using a commercially available, custom-made
stent graft may be both feasible and durable.
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